Gliclazide

Pediatric
  • TRADE NAMES: Adionor; Diamicron (Servier); Diamicron MR (Servier); Diaprel
  • INDICATIONS: Non-insulin dependent diabetes mellitus
  • CLASS: Sulfonylurea
  • HALF-LIFE: 10–12 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Beta andrenergic blocking agents, Chloramphenicol, Cimetidine, Clofibrate, coumarin derivatives, Disopyramide, MAO inhibitors, Miconazole, Phenylbutazone, salicylates, sulfonamides, Tetracycline

PREGNANCY CATEGORY: C

Gliclazide is a sulfonamide and can be absorbed systemically. Sulfonamides can produce severe, possibly fatal, reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome

Our database has 15 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.


Page last updated 09/03/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top